Cite
HARVARD Citation
Kieran, M. et al. (2019). Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma. Neuro-oncology. 21 (4), pp. 537-546. [Online].